SummitTX Capital’s DexCom DXCM Stock Holding History

SummitTX Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-43,560	Closed	-$2.74M	–	843
2026 Q1	$2.74M	Buy	43,560 +40,006	+1,126%	+$2.79M	0.09%	254
2025 Q4	$236K	Sell	3,554 -29,620	-89%	-$1.91M	0.01%	629
2025 Q3	$2.23M	Sell	33,174 -3,321	-9%	-$263K	0.09%	234
2025 Q2	$3.19M	Buy	36,495 +16,484	+82%	+$1.29M	0.14%	179
2025 Q1	$1.37M	Buy	+20,011	New	+$1.63M	0.06%	327

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SummitTX Capital's DXCM Position: Q2 2026 in Review

SummitTX Capital sold out of DexCom (DXCM) in Q2 2026, closing a stake of 43,560 shares — an estimated $2.74M sold.

SummitTX Capital first reported a position in DXCM in Q1 2025 and held it in 5 quarters. The position peaked at $3.19M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

SummitTX Capital reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
SummitTX Capital sold 43,560 DexCom shares in Q2 2026, an estimated $2.74M.
SummitTX Capital first reported a position in DexCom in Q1 2025 and held it in 5 quarters.
SummitTX Capital's DexCom position peaked at $3.19M in Q2 2025.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.